-
1
-
-
0014661330
-
Treatment of multiple myeloma. Combination chemotherapy with different melphalan dose regimens
-
10.1001/jama.208.9.1680 1:STN:280:DyaF1M7ns1Ogtg%3D%3D 5818682
-
R Alexanian 1969 Treatment of multiple myeloma. Combination chemotherapy with different melphalan dose regimens JAMA 208 1680 1685 10.1001/jama.208.9. 1680 1:STN:280:DyaF1M7ns1Ogtg%3D%3D 5818682
-
(1969)
JAMA
, vol.208
, pp. 1680-1685
-
-
Alexanian, R.1
-
2
-
-
0344076348
-
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6, 633 patients form 27 randomized trials
-
The Myeloma Trialists' Collaborative Group
-
The Myeloma Trialists' Collaborative Group 1998 Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6, 633 patients form 27 randomized trials J Clin Oncol 16 3832 3842
-
(1998)
J Clin Oncol
, vol.16
, pp. 3832-3842
-
-
-
3
-
-
0020578180
-
High-dose intravenous melphalan for plasma-cell leukaemia and myeloma
-
10.1016/S0140-6736(83)90739-0 1:STN:280:DyaL2c%2Fht1yktQ%3D%3D 6137651
-
TJ McElwain RL Powles 1983 High-dose intravenous melphalan for plasma-cell leukaemia and myeloma Lancet 2 822 824 10.1016/S0140-6736(83)90739-0 1:STN:280:DyaL2c%2Fht1yktQ%3D%3D 6137651
-
(1983)
Lancet
, vol.2
, pp. 822-824
-
-
McElwain, T.J.1
Powles, R.L.2
-
4
-
-
0023552805
-
High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
-
1:STN:280:DyaL2szgtVWlsA%3D%3D 3304465
-
B Barlogie R Alexanian KA Dicke, et al. 1987 High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma Blood 70 869 872 1:STN:280:DyaL2szgtVWlsA%3D%3D 3304465
-
(1987)
Blood
, vol.70
, pp. 869-872
-
-
Barlogie, B.1
Alexanian, R.2
Dicke, K.A.3
-
5
-
-
8944220233
-
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
-
DOI 10.1056/NEJM199607113350204
-
M Attal JL Harousseau AM Stoppa, et al. 1996 A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma N Engl J Med 335 91 97 10.1056/NEJM199607113350204 1:STN:280: DyaK283ms1emuw%3D%3D 8649495 (Pubitemid 26240110)
-
(1996)
New England Journal of Medicine
, vol.335
, Issue.2
, pp. 91-97
-
-
Attal, M.1
Harousseau, J.-L.2
Stoppa, A.-M.3
Sotto, J.-J.4
Fuzibet, J.-G.5
Rossi, J.-F.6
Casassus, P.7
Maisonneuve, H.8
Facon, T.9
Ifrah, N.10
Payen, C.11
Bataille, R.12
-
6
-
-
0028999439
-
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma
-
1:STN:280:DyaK28%2Fot1OhtQ%3D%3D 7581098
-
JL Harousseau M Attal M Divine, et al. 1995 Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma Bone Marrow Transplant 15 963 969 1:STN:280:DyaK28%2Fot1OhtQ%3D%3D 7581098
-
(1995)
Bone Marrow Transplant
, vol.15
, pp. 963-969
-
-
Harousseau, J.L.1
Attal, M.2
Divine, M.3
-
7
-
-
0030462052
-
An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma
-
N Duncan M Hewetson R Powles, et al. 1996 An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplant 18 1175 1178 1:STN:280:DyaK2s7is1CktA%3D%3D 8971391 (Pubitemid 27026278)
-
(1996)
Bone Marrow Transplantation
, vol.18
, Issue.6
, pp. 1175-1178
-
-
Duncan, N.1
Hewetson, M.2
Powles, R.3
Raje, N.4
Mehta, J.5
-
8
-
-
0032211193
-
High-dose therapy and autologous peripheral stem cell transplantation in multiple myeloma: Up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial
-
1:CAS:528:DyaK1cXntFCqsLs%3D 9787148
-
JP Fermand P Ravaud S Chevret, et al. 1998 High-dose therapy and autologous peripheral stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial Blood 92 3131 3136 1:CAS:528:DyaK1cXntFCqsLs%3D 9787148
-
(1998)
Blood
, vol.92
, pp. 3131-3136
-
-
Fermand, J.P.1
Ravaud, P.2
Chevret, S.3
-
9
-
-
0026729417
-
Double-intensive therapy in high-risk multiple myeloma
-
1:STN:280:DyaK383msF2ntQ%3D%3D 1350228
-
JL Harousseau N Milpied JP Laporte, et al. 1992 Double-intensive therapy in high-risk multiple myeloma Blood 79 2827 2833 1:STN:280:DyaK383msF2ntQ%3D%3D 1350228
-
(1992)
Blood
, vol.79
, pp. 2827-2833
-
-
Harousseau, J.L.1
Milpied, N.2
Laporte, J.P.3
-
10
-
-
0031001279
-
Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
-
1:CAS:528:DyaK2sXptVGluw%3D%3D 9028309
-
B Barlogie S Jagannath DH Vesole, et al. 1997 Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma Blood 89 789 793 1:CAS:528:DyaK2sXptVGluw%3D%3D 9028309
-
(1997)
Blood
, vol.89
, pp. 789-793
-
-
Barlogie, B.1
Jagannath, S.2
Vesole, D.H.3
-
11
-
-
0016804136
-
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
-
10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U 1:STN:280:DyaE28%2FktFCqtA%3D%3D 1182674
-
BG Durie SE Salmon 1975 A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival Cancer 36 842 844 10.1002/1097-0142(197509) 36:3<842::AID-CNCR2820360303>3.0.CO;2-U 1:STN:280:DyaE28%2FktFCqtA%3D%3D 1182674
-
(1975)
Cancer
, vol.36
, pp. 842-844
-
-
Durie, B.G.1
Salmon, S.E.2
-
12
-
-
0030831841
-
Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia
-
10.1038/sj.bmt.1700979 1:STN:280:DyaK1c%2FmslChtw%3D%3D 9404921
-
H Gondo M Harada T Miyamoto, et al. 1997 Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia Bone Marrow Transplant 20 821 826 10.1038/sj.bmt.1700979 1:STN:280:DyaK1c%2FmslChtw%3D%3D 9404921
-
(1997)
Bone Marrow Transplant
, vol.20
, pp. 821-826
-
-
Gondo, H.1
Harada, M.2
Miyamoto, T.3
-
13
-
-
18244428600
-
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation
-
DOI 10.1046/j.1365-2141.1998.00930.x
-
J Blade D Samson D Reece, et al. 1998 Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of EBMT. European Group for Blood and Marrow Transplant Br J Haematol 102 1115 1123 10.1046/j.1365-2141.1998.00930.x 1:STN:280:DyaK1cvitl2mtw%3D%3D 9753033 (Pubitemid 28435189)
-
(1998)
British Journal of Haematology
, vol.102
, Issue.5
, pp. 1115-1123
-
-
Blade, J.1
Samson, D.2
Reece, D.3
Apperley, J.4
Bjorkstrand, B.5
Gahrton, G.6
Gertz, M.7
Giralt, S.8
Jagannath, S.9
Vesole, D.10
-
14
-
-
0037739753
-
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
-
DOI 10.1056/NEJMoa022340
-
JA Child GJ Morgan FE Davies, et al. 2003 High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma N Engl J Med 348 1875 1883 10.1056/NEJMoa022340 1:CAS:528:DC%2BD3sXjsVChtLo%3D 12736280 (Pubitemid 36532313)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.19
, pp. 1875-1883
-
-
Child, J.A.1
Morgan, G.J.2
Davies, F.E.3
Owen, R.G.4
Bell, S.E.5
Hawkins, K.6
Brown, J.7
Drayson, M.T.8
Selby, P.J.9
-
15
-
-
4043090560
-
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
-
DOI 10.1111/j.1600-0609.2004.00282.x
-
H Murakami H Fujii T Inaba, et al. 2004 High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma Eur J Haematol 73 169 173 10.1111/j.1600-0609.2004.00282.x 1:CAS:528:DC%2BD2cXnsVKhsLc%3D 15287913 (Pubitemid 39062239)
-
(2004)
European Journal of Haematology
, vol.73
, Issue.3
, pp. 169-173
-
-
Murakami, H.1
Fujii, H.2
Inaba, T.3
Shimazaki, C.4
Okamoto, S.5
Miwa, A.6
Sawamura, M.7
Abe, M.8
Chou, T.9
Asaoku, H.10
Kitahara, Y.11
Hayashi, K.12
Kosaka, M.13
Togawa, A.14
Takatsuki, K.15
-
16
-
-
0032929769
-
Total therapy with tandem transplants for newly diagnosed multiple myeloma
-
1:STN:280:DyaK1M%2FotFKjsA%3D%3D 9864146
-
B Barlogie S Jagannath KR Desikan, et al. 1999 Total therapy with tandem transplants for newly diagnosed multiple myeloma Blood 93 55 65 1:STN:280:DyaK1M%2FotFKjsA%3D%3D 9864146
-
(1999)
Blood
, vol.93
, pp. 55-65
-
-
Barlogie, B.1
Jagannath, S.2
Desikan, K.R.3
-
17
-
-
0037278820
-
Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial
-
DOI 10.1046/j.1365-2141.2003.04067.x
-
JJ Lahuerta C Grande J Martinez-Lopez, et al. 2003 Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Espanol de Sindromes Linfoproliferativos/ Trasplante Autologo de Medula Osea phase II trial Br J Haematol 120 296 303 10.1046/j.1365-2141.2003.04067.x 1:CAS:528:DC%2BD3sXhs12lt78%3D 12542490 (Pubitemid 36194181)
-
(2003)
British Journal of Haematology
, vol.120
, Issue.2
, pp. 296-303
-
-
Lahuerta, J.J.1
Grande, C.2
Martinez-Lopez, J.3
De La Serna, J.4
Toscano, R.5
Cruz Ortiz, M.6
Larregla, S.7
Conde, E.8
Insunza, A.9
Gonzalez-San Miguel, J.D.10
Bargay, J.11
Cabrera, R.12
Carlos Garcia-Ruiz, J.13
Albo, C.14
Garcia-Alonso, L.15
Solano, F.16
Vivancos, P.17
Leon, A.18
San Miguel, J.19
-
18
-
-
29144520522
-
Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma
-
1:CAS:528:DC%2BD28XltVeisQ%3D%3D 16330437
-
M Galli A Nicolucci M Valentini, et al. 2005 Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma Haematologica 90 1643 1649 1:CAS:528:DC%2BD28XltVeisQ%3D%3D 16330437
-
(2005)
Haematologica
, vol.90
, pp. 1643-1649
-
-
Galli, M.1
Nicolucci, A.2
Valentini, M.3
-
19
-
-
33748122377
-
Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma
-
DOI 10.1093/jjco/hyl041
-
KS Eom CK Min S Lee, et al. 2006 Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma Jpn J Clin Oncol 36 432 438 10.1093/jjco/hyl041 16782727 (Pubitemid 44304801)
-
(2006)
Japanese Journal of Clinical Oncology
, vol.36
, Issue.7
, pp. 432-438
-
-
Eom, K.-S.1
Min, C.-K.2
Lee, S.3
Kim, Y.-J.4
Kim, S.-Y.5
Kim, H.-J.6
Lee, J.-W.7
Min, W.-S.8
Kim, C.-C.9
-
20
-
-
0008893717
-
Peripheral blood progenitor cell collections in multiple myeloma: Predictors and management of inadequate collections
-
DOI 10.1046/j.1365-2141.1996.448987.x
-
HM Prince K Imrie DR Sutherland, et al. 1996 Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections Br J Haematol 93 142 145 10.1046/j.1365-2141.1996.448987.x 1:STN:280:DyaK283gtVCntw%3D%3D 8611448 (Pubitemid 26130723)
-
(1996)
British Journal of Haematology
, vol.93
, Issue.1
, pp. 142-145
-
-
Prince, H.M.1
Imrie, K.2
Sutherland, D.R.3
Keating, A.4
Meharchand, J.5
Crump, R.M.6
Girouard, C.7
Trip, K.8
Stewart, A.K.9
-
21
-
-
0036464598
-
2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: Final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial
-
DOI 10.1182/blood.V99.3.731
-
2 as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma. Final analysis of the IFM 95-02 randomized trial Blood 99 731 735 10.1182/blood.V99.3.731 1:CAS:528: DC%2BD38XhtVals7o%3D 11806971 (Pubitemid 34525530)
-
(2002)
Blood
, vol.99
, Issue.3
, pp. 731-735
-
-
Moreau, P.1
Facon, T.2
Attal, M.3
Hulin, C.4
Michallet, M.5
Maloisel, F.6
Sotto, J.-J.7
Guilhot, F.8
Marit, G.9
Doyen, C.10
Jaubert, J.11
Fuzibet, J.-G.12
Francois, S.13
Benboubker, L.14
Monconduit, M.15
Voillat, L.16
Macro, M.17
Berthou, C.18
Dorvaux, V.19
Pignon, B.20
Rio, B.21
Matthes, T.22
Casassus, P.23
Caillot, D.24
Najman, N.25
Grosbois, B.26
Bataille, R.27
Harousseau, J.-L.28
more..
-
22
-
-
0034055404
-
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone
-
10.1038/sj.bmt.1702167 1:STN:280:DC%2BD3c7nvFGjsg%3D%3D 10713623
-
KR Desikan G Tricot M Dhodapkar, et al. 2000 Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone Bone Marrow Transplant 25 483 487 10.1038/sj.bmt.1702167 1:STN:280:DC%2BD3c7nvFGjsg%3D%3D 10713623
-
(2000)
Bone Marrow Transplant
, vol.25
, pp. 483-487
-
-
Desikan, K.R.1
Tricot, G.2
Dhodapkar, M.3
-
23
-
-
18344374874
-
Myeloablative treatments for multiple myeloma: Update of a comparative study of different regimens used in patients from the Spanish Registry for transplantation in multiple myeloma
-
DOI 10.1080/10428190210194
-
JJ Lahuerta C Grande J Blade, et al. 2002 Myeloablative treatments for multiple myeloma: update of comparative study of different regimens used in patients from the Spanish Registry for Transplantation in Multiple Myeloma Leuk Lymph 43 67 74 10.1080/10428190210194 (Pubitemid 34223972)
-
(2002)
Leukemia and Lymphoma
, vol.43
, Issue.1
, pp. 67-74
-
-
Lahuerta, J.J.1
Grande, C.2
Blade, J.3
Martinez-Lopez, J.4
De La Serna, J.5
Alegre, A.6
Garcia Larana, J.7
Caballero, D.8
DeLa Rubia, J.9
Marin, J.10
Perez-Lopez, C.11
Sureda, A.12
Escudero, A.13
Cabrera, R.14
Conde, E.15
Garcia-Ruiz, J.C.16
Perez-Equiza, K.17
Hernandez, F.18
Palomera, L.19
Leon, A.20
Giraldo, P.21
Solano, C.22
Bargay, J.23
San Miguel, J.24
more..
-
24
-
-
0347815503
-
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
-
DOI 10.1056/NEJMoa032290
-
M Attal JL Harousseau T Facon, et al. 2003 Single versus double autologous stem cell transplantation for multiple myeloma N Engl J Med 349 2495 2502 10.1056/NEJMoa032290 1:CAS:528:DC%2BD3sXhtVWit7vF 14695409 (Pubitemid 38010075)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.26
, pp. 2495-2502
-
-
Attal, M.1
Harousseau, J.-L.2
Facon, T.3
Guilhot, F.4
Doyen, C.5
Fuzibet, J.-G.6
Monconduit, M.7
Hulin, C.8
Caillot, D.9
Bouabdallah, R.10
Voillat, L.11
Sotto, J.-J.12
Grosbois, B.13
Bataille, R.14
-
25
-
-
34347260711
-
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study
-
DOI 10.1200/JCO.2006.10.2509
-
M Cavo P Tosi E Zamagni, et al. 2007 Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study J Clin Oncol 25 2434 2441 10.1200/JCO.2006.10.2509 17485707 (Pubitemid 46999214)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.17
, pp. 2434-2441
-
-
Cavo, M.1
Tosi, P.2
Zamagni, E.3
Cellini, C.4
Tacchetti, P.5
Patriarca, F.6
Di Raimondo, F.7
Volpe, E.8
Ronconi, S.9
Cangini, D.10
Narni, F.11
Carubelli, A.12
Masini, L.13
Catalano, L.14
Fiacchini, M.15
De Vivo, A.16
Gozzetti, A.17
Lazzaro, A.18
Tura, S.19
Baccarani, M.20
more..
-
26
-
-
34548723286
-
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: Long-term follow-up of the Dutch Cooperative Group HOVON 24 trial
-
DOI 10.3324/haematol.11168
-
P Sonneveld B van der Holt CM Segeren, et al. 2007 Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial Hematologica 92 928 935 10.3324/haematol.11168 1:CAS:528:DC%2BD2sXhtFGqu7vM (Pubitemid 350144239)
-
(2007)
Haematologica
, vol.92
, Issue.7
, pp. 928-935
-
-
Sonneveld, P.1
Van Der Holt, B.2
Segeren, C.M.3
Vellenga, E.4
Croockewit, A.J.5
Verhoef, G.E.G.6
Cornelissen, J.J.7
Schaafsma, M.R.8
Van Oers, M.H.J.9
Wijermans, P.W.10
Westveer, P.H.M.11
Lokhorst, H.M.12
-
27
-
-
33644833147
-
Thalidomide and hematopoietic-cell transplantation for multiple myeloma
-
DOI 10.1056/NEJMoa053583
-
B Barlogie G Tricot E Anaissie, et al. 2006 Thalidomide and hematopoietic-cell transplantation for multiple myeloma N Engl J Med 354 1021 1030 10.1056/NEJMoa053583 1:CAS:528:DC%2BD28XitFWluro%3D 16525139 (Pubitemid 43357806)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.10
, pp. 1021-1030
-
-
Barlogie, B.1
Tricot, G.2
Anaissie, E.3
Shaughnessy, J.4
Rasmussen, E.5
Van Rhee, F.6
Fassas, A.7
Zangari, M.8
Hollmig, K.9
Pineda-Roman, M.10
Lee, C.11
Talamo, G.12
Thertulien, R.13
Kiwan, E.14
Krishna, S.15
Fox, M.16
Crowley, J.17
-
28
-
-
22044452126
-
Superiority of thalidomide and dexamethasone over vincristine- doxorubicin- dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma
-
DOI 10.1182/blood-2005-02-0522
-
M Cavo E Zamagni P Tosi, et al. 2005 Superiority of thalidomide and dexamethasone over vincristine-doxorubicin-dexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma Blood 106 35 39 10.1182/blood-2005-02-0522 1:CAS:528:DC%2BD2MXlvVWjs78%3D 15761019 (Pubitemid 40967171)
-
(2005)
Blood
, vol.106
, Issue.1
, pp. 35-39
-
-
Cavo, M.1
Zamagni, E.2
Tosi, P.3
Tacchetti, P.4
Cellini, C.5
Cangini, D.6
De Vivo, A.7
Testoni, N.8
Nicci, C.9
Terragna, C.10
Grafone, T.11
Perrone, G.12
Ceccolini, M.13
Tura, S.14
Baccarani, M.15
-
29
-
-
39749085426
-
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: Comparison with total therapy 2
-
DOI 10.1111/j.1365-2141.2007.06921.x
-
M Pineda-Roman M Zangari J Haessler, et al. 2008 Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2 Br J Haematol 140 625 634 10.1111/j.1365-2141. 2007.06921.x 1:CAS:528:DC%2BD1cXksFSnsLY%3D 18302711 (Pubitemid 351300910)
-
(2008)
British Journal of Haematology
, vol.140
, Issue.6
, pp. 625-634
-
-
Pineda-Roman, M.1
Zangari, M.2
Haessler, J.3
Anaissie, E.4
Tricot, G.5
Van Rhee, F.6
Crowley, J.7
Shaughnessy Jr., J.D.8
Barlogie, B.9
-
30
-
-
44649149612
-
VELCADE/dexamethasone (Vel/D) versus VAD as induction treatment prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (MM): Update results of the IFM 2005/1 trial
-
(abstract)
-
JL Harousseau C Mathiot M Attal, et al. 2007 VELCADE/dexamethasone (Vel/D) versus VAD as induction treatment prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma (MM): update results of the IFM 2005/1 trial Blood 110 139a (abstract)
-
(2007)
Blood
, vol.110
-
-
Harousseau, J.L.1
Mathiot, C.2
Attal, M.3
|